Bethesda, MD, United States of America

Li-Ming Wang

This inventor holds 1 USPTO granted patent. Top assignee: Wake Forest University. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li-Ming Wang. Retrieved from https://idiyas.com/inventor/li-ming-wang-jgwb8icg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis: The Work of Li-Ming Wang

Introduction

Li-Ming Wang, an accomplished inventor based in Bethesda, MD, is making significant strides in the field of cancer diagnostics. With her pioneering work focusing on the sigma-1 receptor, Wang's contributions hold promise for improving non-invasive diagnosis methods for cancer. Her expertise has led to the development of innovative methods and compositions that could potentially revolutionize tumor screening.

Latest Patents

Li-Ming Wang holds a notable patent titled "Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor." This patent describes a new variant of the sigma-1 receptor, which is instrumental in screening compounds that are useful in the imaging and treatment of proliferative masses, particularly tumors. The newly identified variant, referred to as sigma—(σ), plays a critical role in the non-invasive diagnosis of cancer, especially for identifying proliferative cancer cells.

Career Highlights

Wang is associated with Wake Forest University, where her research on the sigma-1 receptor variant is conducted. Her innovative approach to cancer diagnostics marks a significant advancement in medical research, aimed at enhancing the effectiveness of cancer detection methods. Her work has garnered attention within the academic and medical communities, reinforcing her status as a leading inventor in her field.

Collaborations

Throughout her career, Li-Ming Wang has partnered with esteemed colleagues, including Kenneth T. Wheeler and Robert H. Mach. These collaborations reflect her commitment to advancing cancer research and innovation. Together, they work tirelessly to further develop their findings and translate their research into practical applications that can benefit patients.

Conclusion

Li-Ming Wang's contributions to cancer diagnostics through her innovative research on the sigma-1 receptor are paving the way for significant advancements in the field. With her patent securing a foothold in the area of non-invasive cancer diagnosis, Wang exemplifies the spirit of invention and dedication essential for tackling complex medical challenges. Her ongoing work at Wake Forest University, alongside her colleagues, positions her as a key figure in the fight against cancer, with the potential to change the landscape of diagnostic methods profoundly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…